| |
 |
|
Class Information
Number: 514/177
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Cyclopentanohydrophenanthrene ring system doai > Oxygen double bonded to a ring carbon of the cyclopentanohydrophenanthrene ring system
Description: Subject matter wherein a nuclear carbon of the cyclopentanohydrophenanthrene nucleus is bonded to an oxygen atom through a double bond (C=O).
Sub-classes under this class:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7572780 |
Method and kit for reducing the symptoms of peripheral vascular disease |
Aug. 11, 2009 |
| 7521438 |
Combination of loteprednol and .beta..sub.2-adrenoceptor agonists |
Apr. 21, 2009 |
| 7482334 |
Therapeutic treatment methods |
Jan. 27, 2009 |
| 7462646 |
Osteoclastogenesis inhibitors and uses thereof |
Dec. 9, 2008 |
| 7456160 |
Formulation |
Nov. 25, 2008 |
| 7429576 |
Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
Sep. 30, 2008 |
| 7419971 |
Enhancement of activity and/or duration of action of selected anti-inflammatory steroids for topical or other local application |
Sep. 2, 2008 |
| 7402577 |
Androstane 17-beta-carboxamides as androgen receptor modulators |
Jul. 22, 2008 |
| 7371741 |
Estradiol derivatives and pharmaceutical compositions using same |
May. 13, 2008 |
| 7351699 |
Use of DHEA or precursors or metabolic derivatives thereof as a depigmenting agent |
Apr. 1, 2008 |
| 7300669 |
Fluticasone lotion having improved vasoconstrictor activity |
Nov. 27, 2007 |
| 7253155 |
Combinations for the treatment of immunoinflammatory disorders |
Aug. 7, 2007 |
| 7223387 |
Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester |
May. 29, 2007 |
| 7205287 |
Platinum complexes having antitumor activity |
Apr. 17, 2007 |
| 7199115 |
17.alpha.-fluorosteroids, pharmaceutical compositions containing 17.alpha.-fluorosteroids and a method of making them |
Apr. 3, 2007 |
| 7199116 |
Method of modulating the basal metabolic rate of a dieting mammal by administration of a metabolic modulating agent to the dieting mammal |
Apr. 3, 2007 |
| 7186401 |
Dry powder for inhalation |
Mar. 6, 2007 |
| 7182956 |
Stable topical drug delivery compositions |
Feb. 27, 2007 |
| 7182960 |
Pharmaceutical compositions for nasal delivery of oestradiol and norethisterone |
Feb. 27, 2007 |
| 7169768 |
Method of decreasing atherosclerosis and its complications |
Jan. 30, 2007 |
| 7064116 |
GABA.sub.A modulating neurosteroids |
Jun. 20, 2006 |
| 7060694 |
High potency dihydroergotamine compositions |
Jun. 13, 2006 |
| 7053077 |
Use of biogenic estrogen sulfamates for hormone replacement therapy |
May. 30, 2006 |
| 7045513 |
DHEA composition and method |
May. 16, 2006 |
| 7037907 |
Estradiol conjugates and uses thereof |
May. 2, 2006 |
| 7018991 |
17.beta.-amino and hydroxylamino-11 .beta.-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
Mar. 28, 2006 |
| 7005428 |
Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
Feb. 28, 2006 |
| 6977250 |
Prevention of ovarian cancer by administration of progestin products |
Dec. 20, 2005 |
| 6969708 |
Process for the preparation of a high purity composition comprising (7.alpha., 17.alpha.)- 17-hydroxy- 7-methyl- 19-nor-17-pregn-5(10)-en-20-yn-3-one |
Nov. 29, 2005 |
| 6958212 |
Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds |
Oct. 25, 2005 |
| 6949531 |
14 .beta., 16, 17-methylene steroids as novel androgens |
Sep. 27, 2005 |
| 6924274 |
Use of .DELTA.5-androstene-3.beta.-ol-7,17-dione in the treatment of lupus erythematosus |
Aug. 2, 2005 |
| 6906049 |
Contraceptive medicine based on a progestational agent and an oestrogen and preparation method |
Jun. 14, 2005 |
| 6900193 |
Structural modification of 19-norprogesterone I: 17-.alpha.-substituted-11-.beta.-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents |
May. 31, 2005 |
| 6900239 |
Tumor chemopotentiation using isocoumarin derivatives |
May. 31, 2005 |
| 6881728 |
14-.beta., 17-.alpha.-hydroxymethylandrostane derivatives as androgens |
Apr. 19, 2005 |
| 6878699 |
Taccalonolide microtubule stabilizing agents |
Apr. 12, 2005 |
| 6852710 |
2-alkoxyestradiol analogs with antiproliferative and antimitotic activity |
Feb. 8, 2005 |
| 6844320 |
Treatment of preeclampsia, toxemia and preterm labor with combination of progestational agent and a nitric oxide synthase substrate and/or donor |
Jan. 18, 2005 |
| 6831073 |
Hormonal composition consisting of an oestrogen compound and of a progestational compound |
Dec. 14, 2004 |
| 6803060 |
Composition to boost libido |
Oct. 12, 2004 |
| 6777389 |
Cosmetic or dermatological use of 7-hydroxylated steroids in combination with elastin derived peptides |
Aug. 17, 2004 |
| 6774122 |
Formulation |
Aug. 10, 2004 |
| 6767903 |
New7.alpha., 17.alpha.-bis-alkylated testosterone derivatives and their use in long-term therapy of androgen-dependent diseases |
Jul. 27, 2004 |
| 6765001 |
Compositions and methods for enhancing corticosteroid delivery |
Jul. 20, 2004 |
| 6765002 |
Prevention of ovarian cancer by administration of products that induce transforming growth factor-.beta. and/or apoptosis in the ovarian epithelium |
Jul. 20, 2004 |
| 6759400 |
Meiosis regulating compounds |
Jul. 6, 2004 |
| 6737417 |
Compounds with hydroxycarbonyl-halogenoalkyl side chain |
May. 18, 2004 |
| 6723714 |
Aqueous solvent for corticosteroids |
Apr. 20, 2004 |
| 6706700 |
14.beta.,15.beta.-methylene-17.alpha.-hydroxymethyl-androgens |
Mar. 16, 2004 |
|
|
|
